Article
Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells.
Nucleic acids research - 1 Feb 2001
Laurance M E, Starr D B, Michelotti E F, Cheung E, Gonzalez C, Tam A W, Deikman J, Edwards C A, Bardwell A J
Abstract excerpt
Cyclin D1 is expressed at abnormally high levels in many cancers and has been specifically implicated in the development of breast cancer. In this report we have extensively analyzed the cyclin D1 promoter in a variety of cancer cell lines that overexpress the protein and identified two critical regulatory elements (CREs), a previously identified CRE at -52 and a novel site at -30. In vivo footprinting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
